Page last updated: 2024-11-03

proadifen and Breast Neoplasms

proadifen has been researched along with Breast Neoplasms in 2 studies

Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kretschy, N1
Teichmann, M1
Kopf, S1
Atanasov, AG1
Saiko, P1
Vonach, C1
Viola, K1
Giessrigl, B1
Huttary, N1
Raab, I1
Krieger, S1
Jäger, W1
Szekeres, T1
Nijman, SM1
Mikulits, W1
Dirsch, VM1
Dolznig, H1
Grusch, M1
Krupitza, G1
Watts, CK1
Sutherland, RL1

Other Studies

2 other studies available for proadifen and Breast Neoplasms

ArticleYear
In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen.
    British journal of cancer, 2013, Feb-19, Volume: 108, Issue:3

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Acetohexamide; Antineoplastic Combined Chemotherapy Prot

2013
Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Molecular pharmacology, 1987, Volume: 31, Issue:5

    Topics: Animals; Breast Neoplasms; Cell Line; Cyclofenil; Estrogen Antagonists; Humans; Microsomes; Nitromif

1987